Skip to content

Expiratory airflow limitation in subjects with obesity

Expiratory airflow limitation in subjects with obesity - Obesity and EFL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON32007
Enrollment
30
Registered
2008-06-30
Start date
2008-07-22
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity overweight

Interventions

None listed

Sponsors

Medisch Centrum Alkmaar
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria obese population:;Male/female, age 25-60 BMI (body mass index) 30-40 kg/m2 Non or ex smokers with

Exclusion criteria

Exclusion criteria: asthma COPD (FEV1/IVC9% in FEV1 (400 microgram salbutamol) other significant neuromuscular, cardiac or lung disease;Exclusie criteria controle population: asthma COPD (FEV1/FVC9% in FEV1 (400 microgram salbutamol);Exclusion criteria control population: No asthma No COPD (FEV1/FVC9% in FEV1 (400 microgram salbutamol)

Design outcomes

Primary

MeasureTime frame
FEF25-75/FVC mid inspiratory Xrs minus mid expiratory Xrs at 8 Herz (cmH20.s/L)

Secondary

MeasureTime frame
Spirometry: FEV1(L), FVC(L), IC(L), VC max(L), Helium rebreathing: FRC, ERV, TLC Body plethysmography: Pressure-flow loop Forced oscillation technique: Rrs-8 (cmH20.s/L) Frequence dependency Resonance frequency Baseline Xrs, Rrs Anthropometrical data

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)